Parallax Volatility Advisers
PLSE icon

Parallax Volatility Advisers’s Pulse Biosciences PLSE Stock Holding History

Parallax Volatility Advisers’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,428
Closed -$34K – 3723
2017
Q4 		$34K Buy
+1,428
New +$33.7K ﹤0.01% 3424

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Parallax Volatility Advisers's PLSE Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of Pulse Biosciences (PLSE) in Q1 2018, closing a stake of 1,428 shares — an estimated $34K sold.

Parallax Volatility Advisers first reported a position in PLSE in Q4 2017 and held it in 1 quarter. The position peaked at $34K in Q4 2017. 47 funds tracked by Wall St. Rank hold PLSE as of Q1 2018.

  • Parallax Volatility Advisers reported no remaining Pulse Biosciences position as of Q1 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 1,428 Pulse Biosciences shares in Q1 2018, an estimated $34K.
  • Parallax Volatility Advisers first reported a position in Pulse Biosciences in Q4 2017 and held it in 1 quarter.
  • Parallax Volatility Advisers's Pulse Biosciences position peaked at $34K in Q4 2017.
  • 47 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.